Nbm-bmx, an hdac8 inhibitor, overcomes temozolomide resistance in glioblastoma multiforme by downregulating the β-catenin/c-myc/sox2 pathway and upregulating p53-mediated mgmt inhibition

Cheng Yu Tsai, Huey Jiun Ko, Shean Jaw Chiou, Yu Ling Lai, Chia Chung Hou, Tehseen Javaria, Zi Yi Huang, Tai Shan Cheng, Tsung I. Hsu, Jian Ying Chuang, Aij Lie Kwan, Tsung Hsien Chuang, Chi Ying F. Huang, Joon Khim Loh, Yi Ren Hong

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Nbm-bmx, an hdac8 inhibitor, overcomes temozolomide resistance in glioblastoma multiforme by downregulating the β-catenin/c-myc/sox2 pathway and upregulating p53-mediated mgmt inhibition'. Together they form a unique fingerprint.

Engineering & Materials Science

Medicine & Life Sciences

Chemical Compounds

Physics & Astronomy